Pioglitazone Tablets USP, 45 mg, 500 count bottles, Distributed by: Aurobindo Pharma USA, Inc., E...
FDA Recall #D-0450-2022 — Class II — December 29, 2021
Product Description
Pioglitazone Tablets USP, 45 mg, 500 count bottles, Distributed by: Aurobindo Pharma USA, Inc., East Windsor, NJ -- NDC 57237-221-05
Reason for Recall
Superpotent and Failed Tablet/Capsule Specifications
Recalling Firm
Aurobindo Pharma USA Inc. — East Windsor, NJ
Classification
Class II — May cause temporary or medically reversible adverse health consequences.
Product Type
Drugs
Product Quantity
792 bottles
Distribution
Nationwide in the US
Code Information
Batch # PF4520028B & PF4520028A, Exp. Date 11/2022
Status
Terminated
Voluntary / Mandated
Voluntary: Firm initiated